동물용 종양학 시장 : 치료법, 동물 유형, 암 유형별 - 세계 예측(2025-2030년)

The Veterinary Oncology Market was valued at USD 390.30 million in 2023, expected to reach USD 429.72 million in 2024, and is projected to grow at a CAGR of 10.24%, to USD 772.77 million by 2030.

The veterinary oncology market is a niche but rapidly evolving segment, focusing on the diagnosis and treatment of cancer in animals. This field is increasingly becoming a critical aspect of veterinary care due to the rising prevalence of cancer among pets, notably in developed regions where pet ownership and animal healthcare spending are high. The necessity of veterinary oncology lies in the emotional and financial value pet owners place on extending the quality and longevity of their pets' lives, fueling demand for advanced treatments and diagnostics. Applications of veterinary oncology include chemotherapy, radiation therapy, immunotherapy, and surgical interventions, with numerous end-use scope extending to veterinary clinics, hospitals, and specialized cancer treatment centers for animals.

Market growth is significantly influenced by the continuous advancements in veterinary diagnostics, the rising incidence of pet cancer, and the increasing awareness among pet owners about available treatment options. Innovations in veterinary pharmaceuticals and biologics play a crucial role, with targeted therapies and personalized medical approaches paving the way for enhanced treatment protocols. One of the most promising opportunities lies in the development of more affordable and accessible treatment options, as well as the integration of AI and machine learning technologies for early detection and better prognostic tools. However, challenges such as the high cost of treatments, limited insurance coverage, and the emotional burden on pet owners can impede market expansion.

Furthermore, geographical limitations in veterinary oncology infrastructure and the need for more specialized veterinary oncologists underscore potential barriers. To leverage growth opportunities, businesses should focus on R&D initiatives aimed at low-cost, high-efficacy treatment alternatives and explore partnerships with tech companies to enhance diagnostic capabilities. Innovation areas worth exploring include biotechnological advancements and genomic studies to develop more precise and effective therapies. The nature of the veterinary oncology market is highly specialized and rapidly growing, demanding continuous adaptation to technological advancements and changing consumer expectations to sustain business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Oncology Market

The Veterinary Oncology Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Cancer in Pet Animals
  • Growing R&D Initiatives for Cancer Management
  • Technological Advancement in Pet Treatment
• Market Restraints
  • High Cost of Pet Cancer Treatment
• Market Opportunities
  • Rising Awareness Regarding Veterinary Cancer Therapies
  • Favourable Government Initiatives
• Market Challenges
  • Adverse Effect of Drugs used for Pet Cancer Treatment

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Oncology Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Oncology Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Oncology Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Oncology Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Oncology Market

A detailed market share analysis in the Veterinary Oncology Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Oncology Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Oncology Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Oncology Market

A strategic analysis of the Veterinary Oncology Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Oncology Market, highlighting leading vendors and their innovative profiles. These include AB Science SA, Anivive Lifesciences, Ardent Animal Health, LLC, C.H. Boehringer Sohn AG & Ko. KG, Ceva Sante Animale S.A., Covetrus, Inc., Elanco Animal Health Incorporated, ELIAS Animal Health, Fidocure, IDEXX Laboratories, Inc., Karyopharm Therapeutics Inc., Leroy Biotech S.A.S., Morphogenesis, Inc., Nippon Zenyaku Kogyo Co., Ltd., PetCure Oncology LLC, PharmAust Limited, Regeneus Ltd., Rhizen Pharmaceuticals AG, Torigen Pharmaceuticals Inc., Varian Medical Systems, Inc., Vetco Pharmaceuticals Inc., VetDC, Inc., Vetoquinol S.A., Virbac SA, VolitionRx Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Oncology Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Therapy, market is studied across Chemotherapy, Immunotherapy, Radiology, and Surgery.
• Based on Animal Type, market is studied across Canine and Feline.
• Based on Cancer Type, market is studied across Lymphoma, Mammary and Squamous Cell Cancer, and Mast Cell Cancer.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Cancer in Pet Animals
    • 5.1.1.2. Growing R&D Initiatives for Cancer Management
    • 5.1.1.3. Technological Advancement in Pet Treatment
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost of Pet Cancer Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Rising Awareness Regarding Veterinary Cancer Therapies
    • 5.1.3.2. Favourable Government Initiatives
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse Effect of Drugs used for Pet Cancer Treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Oncology Market, by Therapy

• 6.1. Introduction
• 6.2. Chemotherapy
• 6.3. Immunotherapy
• 6.4. Radiology
• 6.5. Surgery

7. Veterinary Oncology Market, by Animal Type

• 7.1. Introduction
• 7.2. Canine
• 7.3. Feline

8. Veterinary Oncology Market, by Cancer Type

• 8.1. Introduction
• 8.2. Lymphoma
• 8.3. Mammary and Squamous Cell Cancer
• 8.4. Mast Cell Cancer

9. Americas Veterinary Oncology Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Veterinary Oncology Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Veterinary Oncology Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AB Science SA
• 2. Anivive Lifesciences
• 3. Ardent Animal Health, LLC
• 4. C.H. Boehringer Sohn AG & Ko. KG
• 5. Ceva Sante Animale S.A.
• 6. Covetrus, Inc.
• 7. Elanco Animal Health Incorporated
• 8. ELIAS Animal Health
• 9. Fidocure
• 10. IDEXX Laboratories, Inc.
• 11. Karyopharm Therapeutics Inc.
• 12. Leroy Biotech S.A.S.
• 13. Morphogenesis, Inc.
• 14. Nippon Zenyaku Kogyo Co., Ltd.
• 15. PetCure Oncology LLC
• 16. PharmAust Limited
• 17. Regeneus Ltd.
• 18. Rhizen Pharmaceuticals AG
• 19. Torigen Pharmaceuticals Inc.
• 20. Varian Medical Systems, Inc.
• 21. Vetco Pharmaceuticals Inc.
• 22. VetDC, Inc.
• 23. Vetoquinol S.A.
• 24. Virbac SA
• 25. VolitionRx Limited
• 26. Zoetis Inc.